1. Home
  2. IFRX vs LFVN Comparison

IFRX vs LFVN Comparison

Compare IFRX & LFVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InflaRx N.V.

IFRX

InflaRx N.V.

HOLD

Current Price

$0.94

Market Cap

60.6M

Sector

Health Care

ML Signal

HOLD

Logo Lifevantage Corporation (Delaware)

LFVN

Lifevantage Corporation (Delaware)

HOLD

Current Price

$4.80

Market Cap

62.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IFRX
LFVN
Founded
2007
N/A
Country
Germany
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
60.6M
62.0M
IPO Year
2017
1996

Fundamental Metrics

Financial Performance
Metric
IFRX
LFVN
Price
$0.94
$4.80
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
$8.50
N/A
AVG Volume (30 Days)
216.6K
112.9K
Earning Date
03-19-2026
05-05-2026
Dividend Yield
N/A
3.77%
EPS Growth
N/A
226.09
EPS
N/A
0.19
Revenue
N/A
$203,204,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1,054.36
N/A
P/E Ratio
N/A
$24.42
Revenue Growth
N/A
1.86
52 Week Low
$0.71
$3.90
52 Week High
$1.94
$16.30

Technical Indicators

Market Signals
Indicator
IFRX
LFVN
Relative Strength Index (RSI) 49.25 42.56
Support Level $0.77 $4.32
Resistance Level $1.16 $5.32
Average True Range (ATR) 0.08 0.31
MACD -0.00 0.01
Stochastic Oscillator 47.91 36.82

Price Performance

Historical Comparison
IFRX
LFVN

About IFRX InflaRx N.V.

InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.

About LFVN Lifevantage Corporation (Delaware)

Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.

Share on Social Networks: